Sofieke P. De Wilde

Amersfoort, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition.

Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition.

Journal: Bone marrow transplantation

Published: July 10, 2025

Adherence to Surgical Antibiotic Prophylaxis in the Field of Vascular Surgery.

Adherence to Surgical Antibiotic Prophylaxis in the Field of Vascular Surgery.

Journal: Surgical infections

Published: January 12, 2022

Gentamicin associated nephrotoxicity under antibiotic stewardship program handling.

Gentamicin associated nephrotoxicity under antibiotic stewardship program handling.

Journal: Infectious diseases (London, England)

Published: June 24, 2021

Improving accurate antimicrobial use for complicated urinary tract infections by antibiotic stewardship intervention.

Improving accurate antimicrobial use for complicated urinary tract infections by antibiotic stewardship intervention.

Journal: Infectious diseases (London, England)

Published: November 27, 2020

A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making.

A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making.

Journal: Cytotherapy

Published: February 07, 2018

EU decision-making for marketing authorization of advanced therapy medicinal products: a case study.

EU decision-making for marketing authorization of advanced therapy medicinal products: a case study.

Journal: Drug discovery today

Published: November 22, 2017

The possibility of obtaining marketing authorization of orphan pharmaceutical compounding preparations: 3,4-DAP for Lambert-Eaton Myasthenic Syndrome.

The possibility of obtaining marketing authorization of orphan pharmaceutical compounding preparations: 3,4-DAP for Lambert-Eaton Myasthenic Syndrome.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: October 05, 2017

Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety.

Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety.

Journal: Pharmacoepidemiology and drug safety

Published: March 24, 2017

Understanding clinical development of chimeric antigen receptor T cell therapies.

Understanding clinical development of chimeric antigen receptor T cell therapies.

Journal: Cytotherapy

Published: January 31, 2017

Clinical development of gene- and cell-based therapies: overview of the European landscape.

Clinical development of gene- and cell-based therapies: overview of the European landscape.

Journal: Molecular therapy. Methods & clinical development

Published: July 19, 2016

Development of cell therapy medicinal products by academic institutes.

Development of cell therapy medicinal products by academic institutes.

Journal: Drug discovery today

Published: February 02, 2016

Hurdles in clinical implementation of academic advanced therapy medicinal products: A national evaluation.

Hurdles in clinical implementation of academic advanced therapy medicinal products: A national evaluation.

Journal: Cytotherapy

Published: December 28, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026